Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2001; 38:1799-1805
© 2001 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pullin, C. H.
Right arrow Articles by McDowell, I. F. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pullin, C. H.
Right arrow Articles by McDowell, I. F. W.

CLINICAL STUDY: RISK FACTORS

Optimization of dietary folate or low-dose folic acid supplements lower homocysteine but do not enhance endothelial function in healthy adults, irrespective of the methylenetetrahydrofolate reductase (C677T) genotype

Catherine H. Pullin, BSca, Pauline A. L. Ashfield-Watt, BAa, Michael L. Burr, MD, FFPHMa, Zoë E. Clark, MPhila, Malcolm J. Lewis, MB, DSc, FESCa, Stuart J. Moat, PhD{dagger}, Robert G. Newcombe, PhD, C. Stats, MFPHM{ddagger}, Hilary J. Powers, PhD{dagger}, Jenny M. Whiting, RGNa and Ian F. W. McDowell, MD, MRCP, FRCPath*,a

a Cardiovascular Sciences Research Group, Wales Heart Research Institute, Cardiff, United Kingdom
{dagger} Centre for Human Nutrition, Division of Clinical Sciences, Northern General Hospital, Sheffield, United Kingdom
{ddagger} Department of Medical Computing and Statistics, University of Wales College of Medicine, Heath Park, Cardiff, United Kingdom

Manuscript received December 6, 2000; revised manuscript received August 15, 2001, accepted August 29, 2001.

* Reprint requests and correspondence: Dr. Ian F. W. McDowell, Department of Medical Biochemistry, University of Wales College of Medicine, Heath Park, Cardiff, CF14 4XN, Wales United Kingdom
mcdowell{at}cardiff.ac.uk

OBJECTIVES

We sought to study the effect of low-dose folic acid supplementation or optimization of dietary folate intake on plasma homocysteine and endothelial function in healthy adults.

BACKGROUND

Elevated homocysteine is associated with cardiovascular disease, but it is not known whether this relationship is causal. Individuals homozygous (TT) for the C677T mutation in the methylenetetrahydrofolate reductase (MTHFR) gene (~12% of the population) have increased homocysteine levels, particularly in association with suboptimal folate intake.

METHODS

Healthy subjects (n = 126; 42 of each MTHFR genotype) were included in this cross-over study of three interventions of four months each: 1) placebo plus natural diet; 2) daily 400-µg folic acid supplement plus natural diet; and 3) increased dietary folate intake to 400 µg/day.

RESULTS

At baseline, homocysteine was inversely related to plasma folate and was higher in TT homozygotes. For the whole group, plasma folate increased by 46% after dietary folate and by 79% after supplementation, with reductions of homocysteine of 14% and 16%, respectively. Within the genotype, TT homozygotes exhibited the most marked changes in these variables. Brachial artery endothelial function, as determined by a change in end-diastolic diameter in response to increased flow, was not changed by increased folate intake (98 ± 73 µm at baseline, 110 ± 69 µm after a high-folate diet, 114 ± 59 µm after supplementation and 118 ± 68 µm after placebo). Plasma von Willebrand factor antigen was unaltered.

CONCLUSIONS

Optimization of dietary folate or low-dose folic acid supplementation reduces plasma homocysteine but does not enhance endothelial function, irrespective of the MTHFR (C667T) genotype.

Abbreviations and Acronyms
  ANOVA = analysis of variance
  FMD = flow-mediated dilation
  MTHFR = methylenetetrahydrofolate reductase
  NO = nitric oxide
  vWF(Ag) = von Willebrand factor (antigen)




This article has been cited by other articles:


Home page
Am. J. Clin. Nutr.Home page
A. de Bree, L. A van Mierlo, and R. Draijer
Folic acid improves vascular reactivity in humans: a meta-analysis of randomized controlled trials
Am. J. Clinical Nutrition, September 1, 2007; 86(3): 610 - 617.
[Abstract] [Full Text] [PDF]


Home page
VASC ENDOVASCULAR SURGHome page
C. J. Abularrage, A. N. Sidawy, P. W. White, G. Aidinian, K. J. DeZee, J. M. Weiswasser, and S. Arora
Effect of Folic Acid and Vitamins B6 and B12 on Microcirculatory Vasoreactivity in Patients With Hyperhomocysteinemia
Vascular and Endovascular Surgery, September 1, 2007; 41(4): 339 - 345.
[Abstract] [PDF]


Home page
CirculationHome page
C. Shirodaria, C. Antoniades, J. Lee, C. E. Jackson, M. D. Robson, J. M. Francis, S. J. Moat, C. Ratnatunga, R. Pillai, H. Refsum, et al.
Global Improvement of Vascular Function and Redox State With Low-Dose Folic Acid: Implications for Folate Therapy in Patients With Coronary Artery Disease
Circulation, May 1, 2007; 115(17): 2262 - 2270.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
A. J.M. de Craen, D. J. Stott, R. G.J. Westendorp, A. Khare, M. Lopez, J. Gogtay, E. P. Quinlivan, J. F. Gregory III, H. Refsum, A. D. Smith, et al.
Homocysteine, B vitamins, and cardiovascular disease.
N. Engl. J. Med., July 13, 2006; 355(2): 205 - 206.
[Full Text] [PDF]


Home page
PediatricsHome page
K. E. MacKenzie, E. J. Wiltshire, R. Gent, C. Hirte, L. Piotto, and J. J. Couper
Folate and Vitamin B6 Rapidly Normalize Endothelial Dysfunction In Children With Type 1 Diabetes Mellitus
Pediatrics, July 1, 2006; 118(1): 242 - 253.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. J. Moat, S. N. Doshi, D. Lang, I. F. W. McDowell, M. J. Lewis, and J. Goodfellow
Treatment of coronary heart disease with folic acid: is there a future?
Am J Physiol Heart Circ Physiol, July 1, 2004; 287(1): H1 - H7.
[Full Text] [PDF]


Home page
J. Nutr.Home page
J. Little, L. Sharp, S. Duthie, and S. Narayanan
Colon Cancer and Genetic Variation in Folate Metabolism: The Clinical Bottom Line
J. Nutr., November 1, 2003; 133(11): 3758S - 3766.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
S. J. Moat, P. A.L. Ashfield-Watt, H. J. Powers, R. G. Newcombe, and I. F.W. McDowell
Effect of Riboflavin Status on the Homocysteine-lowering Effect of Folate in Relation to the MTHFR (C677T) Genotype
Clin. Chem., February 1, 2003; 49(2): 295 - 302.
[Abstract] [Full Text] [PDF]


Home page
Vasc MedHome page
N. Weiss, C. Keller, U. Hoffmann, and J. Loscalzo
Endothelial dysfunction and atherothrombosis in mild hyperhomocysteinemia
Vascular Medicine, August 1, 2002; 7(3): 227 - 239.
[Abstract] [PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement